WinstonWınston
Back
Healthpeak Properties logo

Healthpeak Properties

DOC
42
REIT - Healthcare Facilities · Real Estate
Price
$21.40
+0.20 (+0.94%)
Market Cap
$14.75B
Exchange
New York Stock Exchange
Winston Score
42
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Good
Cash Flow
Exceptional
Stability
Weak
Valuation
Weak
Dividends
Good

Share count rising — dilution

+29.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 539.2M (2021) → 696.0M (2025)

Winston Score History

The full picture

Healthpeak Properties is a real estate company that owns buildings where healthcare happens. Its main properties are medical office buildings, outpatient facilities, and life science lab spaces used by doctors, hospitals, biotech companies, and pharmaceutical researchers. It is one of the largest healthcare-focused real estate investment trusts (REITs) in the United States.

Healthpeak makes money by collecting rent from tenants who lease its properties under long-term contracts, which creates a steady and predictable income stream. The company operates primarily across major U.S. markets, with a large concentration in life science hubs like San Diego, San Francisco, and Boston. Its competitive edge comes from owning specialized buildings that are expensive and difficult to replace, but its main risk is that demand for life science lab space has softened recently as biotech funding has slowed, which could pressure occupancy rates and rental income going forward.

Politician Trades

3 trades / 12mo

2 Congressional buys and 1 sell on DOC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+11.1% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+76.2% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (1%)

Research and development spending

Insider Activity

0.4%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~17 months

$1.6B cash & investments

Quarterly Free Cash Flow

Adequate runway but may need to raise capital within 2 years

Growth context

Healthpeak Properties is growing revenue at 11% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
56.8%
Premium pricing power — 56.8% gross margin
Profit after running costs
Operating Margin
16.2%
Healthy — 16.2% operating margin
Return on the money invested
ROCE
6.6%
Weak — 6.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+5.5%
Slow sales growth (+5.5% YoY)
Profit growth
EPS YoY
+50.7%
Earnings growing fast (+50.7% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
588%
Turns 588% of profit into real cash
Spare cash per sale
FCF Margin
18.1%
Converts sales into free cash efficiently (18.1%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
1.54x
Dangerous — barely covers interest (1.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
61.1x
Expensive — P/E 61.1

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
-117.4
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
5.91%
Healthy income — 5.91% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial